Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
GCTK
GCTK | US
0.67
USD0.00
0.67%
GCTK | US
About GCTK
Sector
Healthcare
Industry
Medical Instruments & Supplies
Earnings date
30/06/2024
As of date
03/06/2026
Close
0.67
Open
0.65
High
0.68
Low
0.64
GlucoTrack Inc. a medical device company focuses on designing developing and commercializing non-invasive glucose monitoring devices for use by people with diabetes in the United States. It develops GlucoTrack a non-invasive blood glucose monitor that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications Inc. and changed its name to GlucoTrack Inc. in November 2021. GlucoTrack Inc. was founded in 2001 and is based in Or Yehuda Israel.
View LessGCTK | US
Risk
157.9
Sharpe
-0.53
Luna's Score
46/100
Recommendation
Hold
Luna says (GCTK | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
136.3%1 month
157.9%3 months
157.7%6 months
134.5%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
21.40
Debt to equity
-0.08
Debt to assets
0.45
Ent. to EBITDA
-1.01
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-12.06M
MarketCap
3.65M
MarketCap(USD)
3.65M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-541.13
Short ratio
1.90
Short perc.
0.57
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.30
Range1M
0.75
Range3M
1.24
Volumes: Market Activity
Rel. volume
0.10
Price X volume
347.03K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.01 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 47.18 | - |
| Price to Book | 21.40 | 5.71 | Expensive |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 157.72 | - | Riskier |
| Debt to Equity | -0.08 | 0.92 | Cheaper |
| Debt to Assets | 0.45 | 0.27 | Expensive |
| Market Cap | 3.65M | - | Emerging |
